We are live on
!
Find out more
FP
Factorial Partners Portfolio holdings
AUM
$138M
1-Year Est. Return
25.59%
This Fund
S&P 500
This Quarter
Est. Return
+3.76%
1 Year Est. Return
+25.59%
3 Year Est. Return
+78.35%
5 Year Est. Return
+78.52%
10 Year Est. Return
–
AUM
$116M
AUM Growth
+$4.54M
(+4.1%)
Cap. Flow
+$2.84M
Cap. Flow
% of AUM
2.44%
Top 10 Holdings %
Top 10 Hldgs %
27.83%
Holding
109
New
11
Increased
29
Reduced
35
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thomson Reuters
TRI
|
+$2.16M |
| 2 |
Abbott
ABT
|
+$1.96M |
| 3 |
Cleveland-Cliffs
CLF
|
+$1.2M |
| 4 |
Johnson & Johnson
JNJ
|
+$1.05M |
| 5 |
Newell Brands
NWL
|
+$845K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.85M |
| 2 |
Norfolk Southern
NSC
|
+$1.02M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$881K |
| 4 |
Vistra
VST
|
+$875K |
| 5 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$804K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.27% |
| 2 | Healthcare | 20.24% |
| 3 | Industrials | 15.21% |
| 4 | Consumer Discretionary | 8.29% |
| 5 | Technology | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Thomson Reuters
TRI
$42.7B
| $817K | 0.7% |
+43,085
| New | +$2.16M |
|
52
Bloomin' Brands
BLMN
$731M
| $788K | 0.68% |
39,800
| – | – |
|
53
Vanguard S&P 500 Value ETF
VOOV
$6.61B
| $771K | 0.66% |
6,900
-2,200
| -24% | -$243K |
|
|
AAMI
54
Acadian Asset Management
AAMI
$2.95B
| $769K | 0.66% |
62,000
| – | – |
|
55
Photronics
PLAB
$1.76B
| $744K | 0.64% |
75,500
+5,000
| +7% | +$46.5K |
|
56
Lantheus
LNTH
$7.03B
| $739K | 0.63% |
49,400
-11,500
| -19% | -$168K |
|
|
TIVO
57
DELISTED
Tivo Inc
TIVO
| $735K | 0.63% |
59,000
+5,000
| +9% | +$64.6K |
|
58
Varex Imaging
VREX
$463M
| $734K | 0.63% |
25,600
+14,200
| +125% | +$467K |
|
59
Viatris
VTRS
$20.5B
| $732K | 0.63% |
+20,000
| New | +$751K |
|
60
AMC Global Media
AMCX
$445M
| $730K | 0.63% |
11,000
| – | – |
|
61
TechnipFMC
FTI
$29.9B
| $725K | 0.62% |
31,181
-18,278
| -37% | -$414K |
|
62
Ichor Holdings
ICHR
$2.73B
| $715K | 0.61% |
+35,000
| New | +$767K |
|
|
63
Eli Lilly
LLY
$1.07T
| $676K | 0.58% |
6,300
-28,500
| -82% | -$2.85M |
|
|
MDR
64
DELISTED
McDermott International
MDR
| $676K | 0.58% |
36,666
+2,000
| +6% | +$37.4K |
|
|
TGI
65
DELISTED
Triumph Group
TGI
| $676K | 0.58% |
29,000
| – | – |
|
|
UCTT
66
Ultra Clean Holdings
UCTT
$3.9B
| $666K | 0.57% |
53,100
+2,000
| +4% | +$29.1K |
|
|
LPNT
67
DELISTED
LifePoint Health, Inc.
LPNT
| $663K | 0.57% |
10,300
-13,200
| -56% | -$804K |
|
68
Alpha and Omega Semiconductor
AOSL
$922M
| $653K | 0.56% |
56,133
| – | – |
|
|
MNK
69
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $648K | 0.56% |
22,100
-31,300
| -59% | -$881K |
|
70
Greenlight Captial
GLRE
$570M
| $644K | 0.55% |
51,900
-8,000
| -13% | -$106K |
|
71
Arq
ARQ
$85.4M
| $635K | 0.55% |
53,057
| – | – |
|
|
AHL
72
DELISTED
ASPEN Insurance Holding Limited
AHL
| $610K | 0.52% |
14,600
-6,700
| -31% | -$268K |
|
|
IVC
73
DELISTED
Invacare Corporation
IVC
| $597K | 0.51% |
41,029
-10,000
| -20% | -$166K |
|
74
Lee Enterprises
LEE
$173M
| $593K | 0.51% |
22,364
| – | – |
|
75
Macy's
M
$6.57B
| $590K | 0.51% |
17,000
-4,000
| -19% | -$149K |
|
Similar funds
TC
PBRA
DFS
LPAM
CI
ACA
LIA
CW
Factorial Partners's Q3 2018 Portfolio in Review
As of Q3 2018, Factorial Partners held 109 positions worth $116M, up 4.1% from $112M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Factorial Partners's Q3 2018 filing shows 11 new, 29 increased, 35 reduced and 9 closed positions. Its largest new stake was Thomson Reuters: 43,085 shares worth $817K. The largest sale was Eli Lilly, an estimated $2.85M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
- Factorial Partners's largest Q3 2018 buy was Thomson Reuters: 43,085 shares worth $817K.
- Factorial Partners added most to Newell Brands in Q3 2018, an estimated $845K increase.
- Factorial Partners's biggest Q3 2018 reduction was Eli Lilly, cutting an estimated $2.85M.
- Factorial Partners fully exited Vistra in Q3 2018, selling an estimated $875K.
- Factorial Partners's ten largest holdings make up 28% of its $116M portfolio in Q3 2018.
- Factorial Partners opened 11 new positions and closed 9 in Q3 2018.
- Factorial Partners's portfolio value rose 4.1% quarter-over-quarter to $116M.
Based on Factorial Partners's 13F filing for Q3 2018, filed 8 Nov 2018.